PHSI-BRG
PHSI-BRG
Home
Staff
Sarah Al Ashmori
Theophile Bigirumurame
Andy Bryant
Thomas Chadwick
Svetlana Cherlin
Mike Cole
Holly Fisher
Tony Fouweather
Shaun Hiu
Dorcas Kareithi
Ann Breeze Konkoth
Nan Lin
Jingky Lozano-Kuehne
Helen Mossop
Ellen Moss
Jérémie Nsengimana
Vicky Ryan
Marzieh Shahmandi
Moha Shojaei
Dawn Teare
James Wason
Faye Williamson
Nina Wilson
Sylvia Zhang
PhD students
Ruqayya Azher
Nicole Cizauskas
Laura Etfer
Niamh Fitzgerald
Raiann Hamshaw
Aritra Mukherjee
Pela Okorie
Samuel Sarkodie
Lou Whitehead
Methodology research
Overview
Adaptive designs
Master protocols
Transforming IMID trials
Projects
Publications
News
Courses
Adaptive Designs and Multiple Testing Procedures
Leveraging External Information
Precision Medicine Clinical Trials
Contact
Light
Dark
Automatic
Grayling
Adaptive Designs: Benefits and Cautions for Neurosurgery Trials
When is a two-stage single-arm trial efficient? An evaluation of the impact of outcome delay
Optimised point estimators for multi-stage single-arm phase II oncology trials
Improving power in PSA response analyses of metastatic castration-resistant prostate cancer trials
Response adaptive intervention allocation in stepped-wedge cluster randomized trials
Advantages of multi-arm non-randomised sequentially allocated cohort designs for Phase II oncology trials
Two-Stage Single-Arm Trials Are Rarely Analyzed Effectively or Reported Adequately
Innovative trial approaches in immune-mediated inflammatory diseases: Current use and future potential
*BMC Rheumatology* 2021; 5:21
Accounting for variation in the required sample size in the design of group-sequential trials
*Contemporary Clinical Trials* 2021; 107:106459
A review of Bayesian perspectives on sample size derivation for confirmatory trials
*The American Statistician* 2021; DOI:10.1080/00031305.2021.1901782
«
»
Cite
×